Pembrolizumab and Odetiglucan in Liver Predominant Metastatic Colorectal Adenocarcinoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Pembrolizumab and Odetiglucan in Liver Predominant Metastatic Colorectal Adenocarcinoma	Colorectal Adenocarcinoma Metastatic in the Liver	Recruiting	Phase 2	2026-10-05		NCT07082439

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Abramson Cancer Center at Penn Medicine	137
Merck Sharp & Dohme LLC	650

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Abramson Cancer Center at the University of Pennsylvania	Philadelphia	United States	8

Clinical trials